A Phase III Study of Apixaban in Patients With Atrial Fibrillation

NCT00496769 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6421

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Acetylsalicylic acid

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]